Citadel Group — Major Shareholding Notification 2023

Apr 11, 2023

National Storage Mechanism | Additional information

RNS Number : 8039V

Citadel Group

11 April 2023

Ap27

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.             KEY INFORMATION

(a)   Full name of discloser	Citadel Group
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.	N/A
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree	HORIZON THERAPEUTICS PLC
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)	N/A
(e)   Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure	10 April 2023
(f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A"	N/A

2.             INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Ap28

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

Class of relevant security (Note 3)	Common Stock ISIN IE00BQPVQZ61
	Interests		Short positions
Number	%	Number	%
(1)   Relevant securities owned and/or controlled	3,757,163	1.64	0	0.00
(2)   Cash-settled derivatives	0	0.00	0	0.00
(3)   Stock-settled derivatives (including options) and agreements to purchase/ sell	0	0.00	0	0.00
Total	3,757,163	1.64	0	0.00

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)           Purchases and sales

Class of relevant security	Purchase/sale	Number of securities	Price per unit (Note 5)
Common	Buy Transaction	85	109.0000 USD
Common	Buy Transaction	1,573	109.3000 USD
Common	Buy Transaction	1,055	109.3100 USD
Common	Buy Transaction	74	109.3140 USD
Common	Buy Transaction	378	109.3142 USD
Common	Buy Transaction	149	109.3143 USD
Common	Buy Transaction	1,269	109.3235 USD
Common	Buy Transaction	3,273	109.3236 USD
Common	Buy Transaction	663	109.3240 USD
Common	Buy Transaction	154	109.3864 USD
Common	Buy Transaction	394	109.3889 USD
Common	Buy Transaction	78	109.3938 USD
Common	Buy Transaction	148	109.4081 USD
Common	Buy Transaction	382	109.4099 USD
Common	Buy Transaction	79	109.4111 USD
Common	Buy Transaction	1,309	109.4171 USD
Common	Buy Transaction	2,070	109.4712 USD
Common	Buy Transaction	5,414	109.4736 USD
Common	Buy Transaction	1,121	109.4755 USD
Common	Buy Transaction	169	109.4872 USD
Common	Buy Transaction	276	109.4877 USD
Common	Buy Transaction	768	109.4902 USD
Common	Buy Transaction	200	109.5700 USD
Common	Buy Transaction	100	109.5800 USD
Common	Buy Transaction	735	109.5894 USD
Common	Buy Transaction	394	109.5896 USD
Common	Buy Transaction	1,917	109.5896 USD
Common	Buy Transaction	2,900	109.6076 USD
Common	Buy Transaction	5,221	109.6142 USD
Common	Buy Transaction	93	109.6490 USD
Common	Buy Transaction	452	109.6492 USD
Common	Buy Transaction	173	109.6495 USD
Common	Buy Transaction	1,000	109.6540 USD
Common	Buy Transaction	100	109.6660 USD
Common	Buy Transaction	296	109.7500 USD
Common	DVP Transaction	741	109.3000 USD
Common	DVP Transaction	1,055	109.3100 USD
Common	RVP Transaction	741	109.3000 USD
Common	RVP Transaction	1,055	109.3100 USD
Common	Sell Transaction	1,035	109.2593 USD
Common	Sell Transaction	741	109.3000 USD
Common	Sell Transaction	506	109.5484 USD
Common	Sell Transaction	25,000	109.5583 USD
Common	Sell Transaction	100	109.5800 USD
Common	Sell Transaction	100	109.5900 USD
Common	Sell Transaction	230,162	109.5922 USD
Common	Sell Transaction	608	109.5945 USD
Common	Sell Transaction	5,000	109.6000 USD
Common	Sell Transaction	8,430	109.6021 USD
Common	Sell Transaction	2,300	109.6130 USD
Common	Sell Transaction	1,700	109.6168 USD
Common	Sell Transaction	200	109.6175 USD
Common	Sell Transaction	100	109.6300 USD
Common	Sell Transaction	1,500	109.6650 USD

Ap29

(b)           Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position	Number of reference securities (Note 6)	Price per unit (Note 5)

(c)           Stock-settled derivative transactions (including options)

(i)            Writing, selling, purchasing or varying

Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates (Note 6)	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit

(ii)           Exercise

Class of relevant security	Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit (Note 5)

(d)           Other dealings (including transactions in respect of new securities) (Note 3)

Class of relevant security	Nature of dealing e.g. subscription, conversion, exercise	Details	Price per unit (if applicable) (Note 5)

Ap30

4.             OTHER INFORMATION

(a)           Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer. Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None

(b)           Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None

(c)           Attachments

Is a Supplemental Form 8 attached?	NO

Date of disclosure	11 April 2023
Contact name	Paula Sharp
Telephone number	020 7645 9700

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEGPUAWCUPWURG